Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
41 |
Material Type: Newsletter Article
|
Clinical Trial: CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCMUS Fed News Service, Including US State News, 2022Copyright HT Digital Streams Limited Jan 12, 2022Digital Resources/Online E-Resources |
|
42 |
Material Type: Newsletter Article
|
Clinical Electrophysiology Journal Issues Research Articles in Jan. 1, 2022 EditionTargeted News Service, 2022Targeted News ServiceDigital Resources/Online E-Resources |
|
43 |
Material Type: Newsletter Article
|
Circulation Journal Issues Research Articles in Nov. 16, 2021 EditionTargeted News Service, 2021Targeted News ServiceDigital Resources/Online E-Resources |
|
44 |
Material Type: Newsletter Article
|
Clinical Trial: Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational StudyUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Nov 5, 2021Digital Resources/Online E-Resources |
|
45 |
Material Type: Newsletter Article
|
European Medicines Agency OKs Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic CardiomyopathyHealth & Beauty Close - Up, 2021Copyright Close-Up Media, Inc. Oct 6, 2021Digital Resources/Online E-Resources |
|
46 |
Material Type: Newsletter Article
|
Towards Uncovering the Splicing Code of the Gigantic Gene Titin in Familial Dilated CardiomyopathyMENA Report, 20212021 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112Digital Resources/Online E-Resources |
|
47 |
Material Type: Newsletter Article
|
Clinical Trial: Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)US Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Aug 28, 2021Digital Resources/Online E-Resources |
|
48 |
Material Type: Newsletter Article
|
United States : Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of U.S. Patents Covering Elamipretide for Barth SyndromeMENA Report, 20212021 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112Digital Resources/Online E-Resources |
|
49 |
Material Type: Newsletter Article
|
Clinical Trial: Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR ParticipantsUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Aug 4, 2021Digital Resources/Online E-Resources |
|
50 |
Material Type: Newsletter Article
|
Clinical Trial: The Maastricht Cardiomyopathy RegistryUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Jul 27, 2021Digital Resources/Online E-Resources |
|
51 |
Material Type: Newsletter Article
|
Alnylam Completes Enrollment In APOLLO-B Phase 3 Study Of Patisiran In Transthyretin-Mediated Amyloidosis Patients With CardiomyopathyBenzinga Newswires, 20212020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
52 |
Material Type: Newsletter Article
|
Clinical Trial: New Horizons for the Treatment of Cardiomyopathy in ChildrenUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited May 20, 2021Digital Resources/Online E-Resources |
|
53 |
Material Type: Newsletter Article
|
Bristol Myers Squibb Highlights New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic CardiomyopathyWireless News, 2021Copyright Close-Up Media, Inc. May 12, 2021Digital Resources/Online E-Resources |
|
54 |
Material Type: Newsletter Article
|
Bristol Myers Squibb Releases New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic CardiomyopathyEntertainment Close - Up, 2021Copyright Close-Up Media, Inc. May 6, 2021Digital Resources/Online E-Resources |
|
55 |
Material Type: Newsletter Article
|
Cardiovascular Imaging Journal Issues Research Articles in May 2021 EditionTargeted News Service, 2021Targeted News ServiceDigital Resources/Online E-Resources |
|
56 |
Material Type: Newsletter Article
|
Clinical Trial: Zinc Deficiency in Dilated CardiomyopathyUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Apr 28, 2021Digital Resources/Online E-Resources |
|
57 |
Material Type: Newsletter Article
|
Clinical Trial: Observational Study for Patients With Hypertrophic CardiomyopathyUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Apr 21, 2021Digital Resources/Online E-Resources |
|
58 |
Material Type: Newsletter Article
|
Institute for Clinical and Economic Review to Assess Treatment for Hypertrophic CardiomyopathyTargeted News Service, 2021Targeted News ServiceDigital Resources/Online E-Resources |
|
59 |
Material Type: Newsletter Article
|
Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy TrialUS Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Apr 2, 2021Digital Resources/Online E-Resources |
|
60 |
Material Type: Newsletter Article
|
Clinical Trial: A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)US Fed News Service, Including US State News, 2021Copyright HT Digital Streams Limited Mar 25, 2021Digital Resources/Online E-Resources |